ESC 365 - Primary Results of SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in People with Asymptomatic High-Risk Carotid Stenosis

ESC Professional Premium Access

Primary Results of SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in People with Asymptomatic High-Risk Carotid Stenosis

Session: Smaller trials and other studies on atherosclerosis

Topic: Drug therapy

Speaker: Professor C. Mazer (Toronto, CA)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor C David Mazer

St. Michaels Hospital University of Toronto, Toronto (Canada)

2 presentations

1 follower

4 more presentations in this session

Effects of Coronary Artery Calcium-Guided Statin Therapy on Atherosclerotic Progression in Intermediate-Risk People with Familial Coronary Artery Disease

Speaker: Doctor N. Nerlekar (Clayton, AU)

Functional Improvement of non-infarcT relaTed coronary artery stenosis by Extensive LDL-C Reduction with a PCSK9 Antibody

Speaker: Mr F. Mensink (Nijmegen, NL)

Treatment of periodontitis and progression of subclinical atherosclerosis: a randomized controlled clinical trial

Speaker: Doctor F. D'Aiuto (London, GB)

Quantified characterization of atherosclerotic plaques by optical coherence tomography attenuation imaging

Speaker: Doctor S. Zhou (Beijing, CN)

Access the full session

Smaller trials and other studies on atherosclerosis

Speakers: Professor C. Mazer, Doctor N. Nerlekar, Mr F. Mensink, Doctor F. D'Aiuto, Doctor S. Zhou

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources